Meeting
2012 Gastrointestinal Cancers Symposium
Patient versus clinician symptom reporting during chemoradiation for rectal cancer.
Authors
Libertad T. Flores
Alpert Medical School of Brown University, Providence, RI
Libertad T. Flores , Antonia V Bennett , Ethel B Law , Carla Hajj , Mindy P Griffith , Karyn A. Goodman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 646)
DOI
10.1200/jco.2012.30.4_suppl.646
Abstract #
646
Poster Bd #
F29
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Factors associated with acute toxicity during chemoradiation therapy for rectal cancer.
First Author: Pooja Monpara
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Toxicities and outcomes of neoadjuvant treatment in elderly patients with locally advanced rectal cancer: A scoping review.
First Author: Ruba Ahmed Mohammed Hamed
Poster
2013 Gastrointestinal Cancers Symposium
Predictors of gastrointestinal toxicity during pelvic radiotherapy.
First Author: T. Jonathan Yang
Poster
2024 ASCO Annual Meeting
Effect of nivolumab combined with definitive chemoradiotherapy on response rate for esophageal cancer: An immune active intrinsic subtype could be its biomarker—The NOBEL trial.
First Author: Manabu Muto